Merz and Macron Unite Amid EU-US Trade Tensions

Strengthening Franco-German Relations Amid Global Challenges German Chancellor Friedrich Merz and French President Emmanuel Macron recently met in Berlin, highlighting the importance of maintaining a strong and unified relationship between their nations. The meeting took place amid a complex landscape of global political and economic challenges, with both leaders emphasizing the need for continued cooperation….

Read More

The AI Divide and Data Dilemma

The Digital Nation Act and the Balancing Act of Innovation and Regulation The Digital Nation Act 2025 has recently been passed by the legislature, sparking a wave of discussion across the country. While many analysts have focused on its implications for cryptocurrency, such as legalizing trading and exchanges or even issuing a digital currency, the…

Read More

Rare Earth and the Mekong’s Looming Crisis

The Growing Threat of Rare Earth Mining in Southeast Asia Recent satellite imagery and research from the Stimson Center have revealed a concerning trend: the rapid expansion of rare earth mining across Southeast Asia, particularly in Myanmar and Laos. These minerals are essential for modern technology, including smartphones, electric vehicles, and renewable energy systems. However,…

Read More

Calls Rise in Morocco to Legalize Traditional Alcohol ‘Mahia’

The Push for Legalization and Regulation of Mahia in Morocco Moroccan civil society groups are increasingly advocating for the legalization and formal regulation of “mahia,” a traditional alcoholic beverage that has long been produced informally across the country. These efforts aim to address the growing concerns around public health, economic opportunities, and cultural preservation. Advocates…

Read More

MindRank’s Phase 3 Trial: China’s First AI-Driven Drug Cuts R&D Costs by 60%

MindRank’s AI-Driven Weight-Loss Drug Advances to Phase 3 Clinical Trials A Hangzhou-based biotech start-up, MindRank, has made significant progress in the development of its weight-loss drug, MDR-001. The company has initiated Phase 3 clinical trials for the drug, marking it as China’s first artificial intelligence-assisted Category 1 new drug to reach this stage. This milestone…

Read More

Why Pebble Jewelry Captivates Designers Worldwide from Agmes to Otiumberg

The Timeless Appeal of Pebbles in Contemporary Jewelry Design Pebbles, with their smooth, tactile, and organic forms, have long captivated designers across the globe. Their natural appeal and simplicity offer a unique blend of elegance and grounding presence that resonates deeply within the world of jewelry design. From sculptural pieces to minimalist accessories, pebbles continue…

Read More